SAN DIEGO, Sept. 25, 2023 /PRNewswire/ Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor therapies, today announced the presentation of.
SAN DIEGO, Sept. 5, 2023 /PRNewswire/ Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today